Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Lipella Pharmaceuticals Inc. LIPO

Full chart Compare
Set alert

Price alert · LIPO

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

1.80 +1.80 +299,916.67%

After hours · Nov 3, 4:00 PM ET

0.0327 Day range 0.058
0.0002 52-week range 0.545
YTD
-99.67%
1 year
-99.86%

Financial health

Altman Z-Score

-18.13 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.6×
FY 2019: -24.0×FY 2020: -25.0×FY 2021: -1.3×FY 2022: -39.1×FY 2023: -10.6×FY 2024: -0.6×
FY 2019 5y median -10.6× FY 2024
P/S 6.0×
FY 2019: 2.2×FY 2020: 1.6×FY 2021: 9.4×FY 2022: 552×FY 2023: 109×FY 2024: 6.0×
FY 2019 5y median 9.4× FY 2024
P/B 1.7×
FY 2019: -12.6×FY 2020: 3.3×FY 2021: 1.7×FY 2022: 21.7×FY 2023: 15.6×FY 2024: 1.7×
FY 2019 5y median 3.3× FY 2024
P/FCF -0.8×
FY 2019: -38.2×FY 2020: -53.6×FY 2021: -2.5×FY 2022: -55.5×FY 2023: -15.5×FY 2024: -0.8×
FY 2019 5y median -15.5× FY 2024
EV/EBITDA -0.2×
FY 2019: 0.0×FY 2020: -24.5×FY 2021: -0.7×FY 2022: -37.5×FY 2023: -9.9×FY 2024: -0.2×
FY 2019 5y median -9.9× FY 2024
EV/Sales 2.0×
FY 2019: 2.3×FY 2020: 1.4×FY 2021: 5.1×FY 2022: 526×FY 2023: 102×FY 2024: 2.0×
FY 2019 5y median 5.1× FY 2024
FCF Yield -123.6%
FY 2019: -2.6%FY 2020: -1.9%FY 2021: -40.4%FY 2022: -1.8%FY 2023: -6.5%FY 2024: -123.6%
FY 2019 5y median -6.5% FY 2024

Profitability

Gross Margin -573.7%
FY 2019: 1.7%FY 2020: -1.5%FY 2021: -461.7%FY 2022: -1283.4%FY 2023: -575.9%FY 2024: -573.7%
FY 2019 5y median -573.7% FY 2024
Operating Margin -947.2%
FY 2019: -7.7%FY 2020: -5.9%FY 2021: -738.7%FY 2022: -1406.3%FY 2023: -1055.6%FY 2024: -947.2%
FY 2019 5y median -947.2% FY 2024
Net Margin -935.2%
FY 2019: -8.9%FY 2020: -6.4%FY 2021: -719.3%FY 2022: -1410.6%FY 2023: -1027.3%FY 2024: -935.2%
FY 2019 5y median -935.2% FY 2024
ROE -261.3%
FY 2019: 52.3%FY 2020: -13.3%FY 2021: -131.0%FY 2022: -55.6%FY 2023: -146.9%FY 2024: -261.3%
FY 2019 5y median -131.0% FY 2024
ROIC -258.3%
FY 2019: -1657.7%FY 2020: -6.5%FY 2021: -110.3%FY 2022: -50.7%FY 2023: -144.6%FY 2024: -258.3%
FY 2019 5y median -110.3% FY 2024
ROA -187.6%
FY 2019: -52.0%FY 2020: -6.5%FY 2021: -92.7%FY 2022: -43.7%FY 2023: -129.1%FY 2024: -187.6%
FY 2019 5y median -92.7% FY 2024

Growth (YoY)

Revenue 19.3%
FY 2019: 0.0%FY 2020: 38.4%FY 2021: -73.0%FY 2022: -29.0%FY 2023: 144.2%FY 2024: 19.3%
FY 2019 FY 2024
Operating Income -7.0%
FY 2019: 0.0%FY 2020: -5.7%FY 2021: -3269.3%FY 2022: -35.2%FY 2023: -83.3%FY 2024: -7.0%
FY 2019 FY 2024
EPS (diluted) 22.2%
FY 2019: 0.0%FY 2020: 4.2%FY 2021: -1804.3%FY 2022: -16.9%FY 2023: -20.3%FY 2024: 22.2%
FY 2019 FY 2024
Free Cash Flow -24.8%
FY 2019: 0.0%FY 2020: 26.9%FY 2021: -3361.8%FY 2022: -85.1%FY 2023: -72.8%FY 2024: -24.8%
FY 2019 FY 2024

Financial Health

Current Ratio 3.5×
FY 2019: 0.7×FY 2020: 3.4×FY 2021: 5.3×FY 2022: 4.9×FY 2023: 8.9×FY 2024: 3.5×
FY 2019 5y median 4.9× FY 2024
Quick Ratio 3.5×
FY 2019: 0.7×FY 2020: 3.4×FY 2021: 5.3×FY 2022: 4.9×FY 2023: 8.9×FY 2024: 3.5×
FY 2019 5y median 4.9× FY 2024
Debt / Equity 0.0×
FY 2019: -0.8×FY 2020: 0.8×FY 2021: 0.2×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×
FY 2019 5y median 0.1× FY 2024
Net Debt / EBITDA 0.4×
FY 2019: 0.0×FY 2020: 4.1×FY 2021: 0.6×FY 2022: 1.8×FY 2023: 0.7×FY 2024: 0.4×
FY 2019 5y median 0.7× FY 2024
Interest Coverage 0.0×
FY 2019: -6.4×FY 2020: -7.1×FY 2021: -280×FY 2022: -269×FY 2023: -437×FY 2024: 0.0×
FY 2019 5y median -269× FY 2024

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31